Kingfish Limited/Announcement
Kingfish Limited logo

KFL – June 2018 Quarter Update Newsletter

Operational Update17 July 2018KFLFinancials

1
Notable Returns in the Quarter

»»The»June»quarter»was»a»positive»one»for»the»New»Zealand»

market»with»the»S&P/NZX50G»up»+7.5%,»a»strong»rebound»

after»the»volatile»March»quarter.

»»The»Kingfish»portfolio»delivered»a»gross»performance»return»

of»+8.2%»for»the»quarter»with»the»majority»of»portfolio»

companies»delivering»positive»returns.»

»»We»spent»some»time»abroad»recently,»visiting»the»operations»

of»several»of»Kingfish’s»core»holdings»and»hearing»from»

management»about»key»developments»in»their»offshore»

businesses.

The New Zealand share market performed strongly for the three

months to 30 June, with gains increasing steadily each month. This

was in contrast to the volatile first quarter of the 2018 calendar year,

and made the New Zealand market one of the best performing

globally for the six months to 30 June 2018.

The Kingfish portfolio also performed strongly over the quarter,

rising 8.2% on a gross performance basis. Kingfish’s performance

was supported by the standout performance of Vista»Group which

rose +34% over the period, while nine other portfolio companies

posted double digit returns including Fisher»&»Paykel»Healthcare

(+14%) and Mainfreight (+13%). Recent portfolio addition,

Fletcher»Building, contributed positively to performance rising

13% since the position was first initiated in April.

Fisher Funds hits the road

Various investing legends have long espoused the virtues of

‘wearing out your shoe leather’ and visiting businesses first hand

to gain a more direct perspective. It certainly makes a welcome

change from reading financial reports and searching for unique

insights from the terabytes of information constantly circulating the

internet.

We are often talking and meeting with companies locally, but with

around half of Kingfish’s portfolio companies’ revenue generated

offshore, we think it is also important to get overseas and see the

offshore operations and key staff of these businesses first hand. So in

June we hit the road and visited a number of the offshore business

units of some of Kingfish’s core holdings, gaining valuable insights

into operations and hearing from local management directly.

As part of our trip, we were fortunate to see progress in

Mainfreight’s burgeoning European and Australian operations,

and attend the most recent investor day held in the Netherlands.

Currently, Mainfreight is growing revenues rapidly in Australia

and Europe and the company’s progress was evident. We spent

time at the large Epping site in Melbourne where the warehouse

was full and the quality of the operations at the site have been

attracting a significant number of new customers. As a result,

the company is already expanding onto an adjacent site. We

VISTA GROUP

+34

%

RYMAN

HEALTHCARE

+14

%

FISHER & PAYKEL

HEALTHCARE

+14

%

MAINFREIGHT

+13

%

FLETCHER

BUILDING

+13

%

were also encouraged by the recent investor day being held in

the Netherlands - a testament to the progress in the European

business, and were pleased to see the company continuing to

foster its unique culture offshore and intensify its network both

within, and between, regions.

When we were in Europe we visited Fisher & Paykel Healthcare’s

Head of European Operations, Patrick McSweeney, who is based

in France. Fisher & Paykel Healthcare generates almost 10% of

its revenue from Europe so it was extremely helpful to spend

some time with Patrick who has been in the medical technology

industry for 30 years and with Fisher & Paykel Healthcare for 15

years. In business generally, but especially in the world of medtech,

where timeframes to get products approved and into commercial

production are measured in decades, not years, Patrick’s

experience is worth its weight in gold. We gained a number of

valuable insights into the European business. Patrick also reminded

us that the European and global penetration of high flow oxygen

therapies into hospitals is still very low and that there are significant

growth runways available to the company. We agree with Patrick

that Fisher & Paykel Healthcare remains very well positioned to

dominate this significant opportunity for many years to come. As at

30 June, Fisher & Paykel Healthcare was the largest position in the

Kingfish portfolio.

We also had a number of meetings with The»a2»Milk»Company

distributors based in China and Hong Kong, which gave us the

opportunity to see the daigou channel in action and get on the

ground insights. During the quarter, we chose to increase the

Kingfish investment in The a2 Milk Company as new data shows

the company increasing its market share in China.

Fletcher Building added to the portfolio

As discussed in the recent Kingfish Annual Report, we added

Fletcher Building to the portfolio early in the quarter, taking

an initial 3% position size. Despite the well-publicised and

somewhat turbulent events of the last couple of years, we think

several key things have changed at Fletcher Building which have

acted as a catalyst for Kingfish taking a position.

Fletcher Building has undertaken a strategic review guided by the

new management team and committed to a “back to the future”

strategy - selling its overseas business, refocusing on the strong

New Zealand and Australian core.

Quarter Update Newsletter

31 March 2018 – 30 June 2018

NAV

$

1.52

SHARE PRICE

$

1.39

as»at»30»June»2018

DISCOUNT

8.6

%

2
Disclaimer: The information in this newsletter has been prepared as at the date noted on the front page. The information has been prepared as a general summary of the matters covered only, and it is

by necessity brief. The information and opinions are based upon sources which are believed to be reliable, but Kingfish Limited and its officers and directors make no representation as to its accuracy

or completeness. The newsletter is not intended to constitute professional or investment advice and should not be relied upon in making any investment decisions. Professional financial advice from

an authorised financial adviser should be taken before making an investment. To the extent that the newsletter contains data relating to the historical performance of Kingfish Limited or its portfolio

companies, please note that fund performance can and will vary and that future results may have no correlation with results historically achieved.

Kingfish Limited

Private Bag 93502, Takapuna, Auckland 0740, New Zealand

Phone: +64 9 489 7094 | Fax: +64 9 489 7139

Email: enquire@kingfish.co.nz | www.kingfish.co.nz

If you would like to receive future

newsletters electronically please email

us at enquire@kingfish.co.nz

Performance

as at 30 June 2018

3 Months

3 Years

(annualised)

Five Years

(annualised)

Corporate Performance

Total Shareholder Return+8.4%+9.9%+12.4%

Adjusted NAV Return+7.2%+15.6%+13.4%

Manager Performance

Gross Performance Return+8.2%+18.3%+16.2%

S&P/NZX50G Index+7.5%+16.0%+15.0%


Non-GAAP Financial Information

Kingfish uses non-GAAP measures, including adjusted net asset value, adjusted NAV return, gross performance

return and total shareholder return. The rationale for using such non-GAAP measures is as follows:

»adjusted net asset value – the underlying value of the investment portfolio adjusted for capital allocation

decisions after fees and tax,

»adjusted NAV return – the net return to an investor after fees and tax,

»gross performance return – the Manager’s portfolio performance in terms of stock selection, and

»total shareholder return – the return to an investor who reinvests their dividends, and if in the money,

exercises their warrants at warrant maturity date for additional shares.

All references to adjusted net asset value, adjusted NAV return, gross performance return and total shareholder

return in this newsletter are to such non-GAAP measures. The calculations applied to non-GAAP measures are

described in the Kingfish Non-GAAP Financial Information Policy. A copy of the policy is available at

http://www.kingfish.co.nz/about-kingfish/kingfish-policies/

LISTED»COMPANIES

%»Holding

Abano Healthcare

1.8%

Auckland International Airport5.0%

Delegat Group3.3%

Fisher & Paykel Healthcare12.1%

Fletcher Building3.1%

Freightways9.2%

Infratil7.1%

Mainfreight10.7%

Meridian Energy3.0%

Michael Hill International3.9%

Port of Tauranga2.5%

Restaurant Brands NZ5.0%

Ryman Healthcare7.7%

Summerset6.2%

The a2 Milk Company7.5%

Vista Group International4.9%

Equity»Total93.0%

New Zealand dollar cash7.0%

TOTAL100.0%

Portfolio Holdings Summary

as at 30 June 2018

Company News

Dividend Paid 29 June 2018

A dividend of 2.89 cents per share was paid to Kingfish shareholders

on 29 June 2018 under the quarterly distribution policy. Interest

in Kingfish’s dividend reinvestment plan (DRP) remains high with

45% of shareholders participating in the plan. Shares issued to

DRP participants are at a 3% discount to market price. If you would

like to participate in the DRP, please contact our share registrar,

Computershare on (09) 488 8777.

We think the company’s decision to sell its overseas businesses

(Formica and Roof Tiles are currently up for sale) is likely to

generate in excess of $1bn for the company and may result in

it being able to return capital to shareholders. Additionally, the

New Zealand and Australian core comprises a number of key

operations such as Golden Bay Cement, Winstone Wallboards

and PlaceMakers which dominate their respective markets. These

core businesses have clear moats and help the company to

deliver solid cash flow.

We are encouraged by Fletcher’ Buildings new CEO, Ross Taylor.

To date, we think Ross has made the right moves to strengthen

and refocus the business through repairing the balance sheet

and plans to divest the non-core international operations. The

recently presented strategic plan is logical and sets expectations

of improved performance across the portfolio, with investment

where necessary. 2018 earnings guidance has been reiterated

with no new provisions expected for the problematic Building

and Interiors division, which is being wound down.

Ultimately, we believe the extent of Fletcher Building’s success will

be determined by how well its new strategy is executed. So far

the right building blocks appear to be in place and the stock has

performed well since we initiated the Kingfish portfolio position.

Sam»Dickie»

Senior Portfolio Manager

18 July 2018

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.